Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting of intracellular oncoproteins with peptide-centric CARs. | Nature | 2023 | 37938771 | PubTator, text mining | PubMed |
| Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy. | Front Immunol | 2023 | 37936697 | PubTator, text mining | PubMed |
| Adoptive cell therapy for cancer treatment. | Exploration (Beijing) | 2023 | 37933232 | PubTator, text mining | PubMed |
| Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival. | Cancer Diagn Progn | 2023 | 37927813 | PubTator, text mining | PubMed |
| Recent advances in neoantigen vaccines for treating non-small cell lung cancer. | Thorac Cancer | 2023 | 37905603 | PubTator, text mining | PubMed |
| Tumor vaccines: Toward multidimensional anti-tumor therapies. | Hum Vaccin Immunother | 2023 | 37905395 | PubTator, text mining | PubMed |
| Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment. | Biomedicines | 2023 | 37892995 | PubTator, text mining | PubMed |
| Molecular characterization of ferroptosis in soft tissue sarcoma constructs a prognostic and immunotherapeutic signature through experimental and bioinformatics analyses. | Aging (Albany NY) | 2023 | 37874682 | PubTator, text mining | PubMed |
| Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma. | Int Immunopharmacol | 2023 | 37866309 | PubTator, text mining | PubMed |
| CDKN2A was a cuproptosis-related gene in regulating chemotherapy resistance by the MAGE-A family in breast cancer: based on artificial intelligence (AI)-constructed pan-cancer risk model. | Aging (Albany NY) | 2023 | 37857018 | PubTator, text mining | PubMed |
| Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptors. | Front Immunol | 2023 | 37849763 | PubTator, text mining | PubMed |
| Exploring alternative approaches to precision medicine through genomics and artificial intelligence - a systematic review. | Front Med (Lausanne) | 2023 | 37849490 | PubTator, text mining | PubMed |
| Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer. | Diagnostics (Basel) | 2023 | 37835834 | PubTator, text mining | PubMed |
| Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives. | Diagnostics (Basel) | 2023 | 37835765 | PubTator, text mining | PubMed |
| Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy. | Int J Mol Sci | 2023 | 37834126 | PubTator, text mining | PubMed |
| The role of CD4+ T cells in tumor and chronic viral immune responses. | MedComm (2020) | 2023 | 37829505 | PubTator, text mining | PubMed |
| Immunization with a multi-antigen targeted DNA vaccine eliminates chemoresistant pancreatic cancer by disrupting tumor-stromal cell crosstalk. | J Transl Med | 2023 | 37814317 | PubTator, text mining | PubMed |
| Evolution by innovation as a driving force to improve TCR-T therapies. | Front Oncol | 2023 | 37810959 | PubTator, text mining | PubMed |
| Skin cancer: understanding the journey of transformation from conventional to advanced treatment approaches. | Mol Cancer | 2023 | 37803407 | PubTator, text mining | PubMed |
| Post-translational modifications and their implications in cancer. | Front Oncol | 2023 | 37795435 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=8